DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 1.86% to $184.38 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.80% to 7,165.08 and the Dow Jones Industrial Average falling 0.16% to 49,230.71.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 8.91% short of its 52-week high of $202.41, which the company reached on February 6th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 1.37% to $227.50, Pfizer Inc. $(PFE)$ rose 1.24% to $27.00, and AbbVie Inc. $(ABBV)$ fell 1.11% to $198.71.
Trading volume (723,253) remained 399,646 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 24, 2026 17:00 ET (21:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments